BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35465819)

  • 21. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of non-invasive prenatal testing in preventing birth defects].
    Zhang W; Li S; Tang P; Wang J; Gu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1061-1064. PubMed ID: 32924101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
    Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
    Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical application and evaluation of health economics for non-invasive prenatal testing of fetuses in Tianjin].
    Ma R; Li X; Xu S; Shi Y; Ju D; Li Y; Meng F; Wang X; Du X; Xu N; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):135-142. PubMed ID: 36709929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?
    Dai P; Yang Y; Zhao G; Gu Z; Ren H; Hu S; Liu N; Jiao W; Li J; Kong X
    J Transl Med; 2022 Jun; 20(1):269. PubMed ID: 35706031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
    El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of the results of chromosomal trisomies 21, 18 and 13 screening among 40 628 women by non-invasive prenatal testing].
    Wang D; Yang J; Peng H; Hou Y; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1045-1050. PubMed ID: 34729740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
    BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive prenatal testing (NIPT) in twin pregnancies affected by early single fetal demise: A systematic review of NIPT and vanishing twins.
    van Eekhout JCA; Bekker MN; Bax CJ; Galjaard RH
    Prenat Diagn; 2023 Jun; 43(7):829-837. PubMed ID: 37226326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report.
    Xu HH; Dai MZ; Wang K; Zhang Y; Pan FY; Shi WW
    BMC Med Genomics; 2020 Jul; 13(1):96. PubMed ID: 32631433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin.
    Kleinfinger P; Luscan A; Descourvieres L; Buzas D; Boughalem A; Serero S; Valduga M; Trost D; Costa JM; Vivanti AJ; Lohmann L
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.
    Zhou Q; Pan L; Chen S; Chen F; Hwang R; Yang X; Wang W; Jiang J; Xu J; Huang H; Xu C
    Prenat Diagn; 2014 Nov; 34(11):1061-5. PubMed ID: 24899146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.